Skip to content
  • info@eledon.com
  • +1 949.238.8090
  • Home
  • About Us
    • Company Overview
    • Leadership Team
    • Board of Directors
    • Governance
  • R&D
    • R&D Overview
    • CD40L Pathway
    • Pipeline
    • tegoprubart
    • Phase 1 KLH Challenge
  • Investors
    • News
    • Events
    • Presentations
    • Stock Information
    • SEC Filings
    • Investor FAQs
  • Join the Team
  • Contact Us

test

Eledon announces positive topline results from Phase 2a trial of tegoprubart in patients with Amyotrophic Lateral Sclerosis

Quick links

  • Home
  • About Us
  • CD40L Pathway
  • Pipeline
  • tegoprubart
  • KLH Challenge
  • Contact Us

 

  • Investors
  • Press Releases
  • Governance
  • Stock Information
  • SEC Filings
  • Investor Email List
© 2021 Eledon Pharmaceuticals, Inc. - All Rights Reserved.